221 followers
1,664 followers
@jamesfomahony @AnkurFactorial @TorbWis @mikepaulden @WrightCensored @eline_aas @HenrikssonX @ArthurAttema Look forward to our ideas on why the theory is more complex. Bottom line is that relevant changes in value should be captured in economic evaluations
1,664 followers
@AnkurFactorial @TorbWis @mikepaulden @WrightCensored @jamesfomahony @eline_aas @HenrikssonX The theory underlying differential discounting is convincing and straightforward imo (see e.g. paper with @ArthurAttema & Karl Claxton: https://t.co/4jNr0J3GFd
2,448 followers
RT @werner_brouwer: Thanks Paul! If useful, here is a more recent one as well: https://t.co/4jNr0J3GFd
1,664 followers
Thanks Paul! If useful, here is a more recent one as well: https://t.co/4jNr0J3GFd
287 followers
Discounting in Economic Evaluations - I wasn't aware of the issue of 'double discounting' before: https://t.co/urA9XXkHus
1,648 followers
Discounting in Economic Evaluations https://t.co/OiOB5hhCoz
627 followers
RT @HealthEconRdam: In a new issue of Pharmacoeconomics, @ArthurAttema, @werner_brouwer and Karl Claxton review discounting issues and deba…
442 followers
RT @HealthEconRdam: In a new issue of Pharmacoeconomics, @ArthurAttema, @werner_brouwer and Karl Claxton review discounting issues and deba…
2,448 followers
In a new issue of Pharmacoeconomics, @ArthurAttema, @werner_brouwer and Karl Claxton review discounting issues and debates, and discuss national discounting guidelines. https://t.co/kpxYqHvUI3 @ESHPM_EUR
808 followers
Love it ❤️ https://t.co/TUbkIbFqyy
721 followers
#HealthEconJA Discounting in Economic Evaluations https://t.co/sgx11asFyf